🚀COUNTDOWN Day 2 of 5: Bridging The Gap
🌅 On Day 2 of 5 of our 11th Birthday Fundraiser Countdown, we illuminate our CERI Personalized Patient Program™, dedicated to bridging the gap between cancer professionals and cancer patients, breaking the healthcare system to ensure access to high-quality cancer care for all.

The 114% surge in patient applications in 2023 highlights the critical need for your support, especially as our internet and website hosting costs have more than doubled.

We need your help more than ever!

Contribute and help us make the Day 2 of 5 countdown extraordinary! 🌟

We need 75 people to donate today, on Day 2.
So, please donate whatever you can and ask 3 people to do the same. 

Donate NOW at canceredinstitute.org/donate and share it with 3 people.

Thank you for caring and sharing!

Share your stories using #BridingTheGap and contribute to our mission. Let's bridge the gap together! 💙

#PatientSupport #DonateNow #BridgingTheGap

The efficacy was evaluated in:

• 71 ROS1 TKI-naïve patients who received up to 1 prior line of platinum-based chemotherapy and/or immunotherapy and, 
• 56 patients who received 1 prior ROS1 TKI with no prior platinum-based chemotherapy or immunotherapy.

Confirmed overall response rate (ORR):

• In the ROS1 TKI naïve group: 79% (95% CI: 68, 88) 
• In the prior treatment with a ROS1 inhibitor group: 38% (95% CI: 25, 52)

Median duration of response (DOR):

• In the ROS1 TKI naïve group: 34.1 months (95% CI: 25.6, not evaluable)
• In the prior treatment with a ROS1 inhibitor group: 14.8 months (95% CI: 7.6, not evaluable)

​
Responses were observed in intracranial lesions in patients with measurable Central Nervous System (CNS) metastases, and in patients with resistance mutations following TKI therapy.

Side Effects: 
The most common (more than 20%) adverse reactions were:

• dizziness
• dysgeusia
• peripheral neuropathy
• constipation
• dyspnea
• ataxia
• fatigue
• cognitive disorders
• muscular weakness

Recommended Dose:
The recommended repotrectinib dose is 160 mg orally once daily with or without food for 14 days, then increased to 160 mg twice daily, until disease progression or unacceptable toxicity.

✅ Want to make a difference in the world with your support and leadership? Learn more and apply online:

👉https://canceredinstitute.org/board

✅ Want to make a difference worldwide as a CERI Team Member? You can help in many ways - find more information and apply on our website:

👉https://canceredinstitute.org/volunteer

PS: If you have expertise in any of the following areas, we, particularly, would love to hear from you!
Not seeing your expertise area below?
No worries!
**Every talented person with a passion for our mission is welcome to apply!**

🔸️URGENT RECRUITMENT (with stipend): Program Assistant for our CERI Personalized Patient Program. 
🔸️German, Arabic, Spanish, and Italian translation (native speakers)
🔸️Development/Fundraising
🔸️Research (literature/writing)
🔸️Science and/or Medicine
🔸️Grant writing
🔸️Outreach
🔸️Database research
🔸️Events
🔸️Social media
🔸️Marketing & PR
🔸️HR (Human Resources)
🔸️Assistant to Executive Director/Secretary
🔸️Accounting

___________
#board #volunteer #team #recruitment #apply #cancer #health

⚜️We are so excited to have Rüya from Canada join us as part of our CERI Youth Program. Rüya joins us as a CERI Research Team Member, Mentee, and Ambassador-Canada. She is 12 years old and always had an interest in biology and medicine. Rüya believes that becoming a volunteer for CERI will aid in cancer awareness and prevention, along with educating people about the disease in order to catch and effectively treat cancer in the earlier stages of its development.
We are truly excited to have Rüya in our team and we can't wait to share with you her work on various cancers as well as cancer prevention methods starting from September.

🎉Welcome to CERI, Rüya - we are glad to have you onboard!

✅️ canceredinstitute.org/volunteer 
  #CERICares 

⚜️CERI Gençlik Programımız kapsamında Kanada'dan Rüya'nın da aramıza katılmasından büyük mutluluk duyuyoruz. Rüya, CERI Araştırma Ekibi Üyesi, Mentee ve Kanada elçisi olarak aramıza katılıyor. 12 yaşında ve her zaman biyoloji ve tıpla ilgileniyordu. Rüya, CERI gönüllüsü olmanın, kanserin erken evrelerinde yakalanması ve etkili bir şekilde tedavi edilmesi için insanları hastalık konusunda eğitimin yanı sıra, kanser farkındalığı ve önlenmesine de yardımcı olacağına inanıyor.
Rüya'nın ekibimizde olmasından büyük heyecan duyuyoruz ve Eylül ayından itibaren çeşitli kanser türleri ve kanserden korunma yöntemleri üzerine yaptığı çalışmaları sizlerle paylaşmak için sabırsızlanıyoruz.

🎉CERI'ye hoşgeldin Rüya!

⚜️Wir freuen uns sehr, dass Rüya aus Kanada Teil unseres CERI-Jugendprogramms ist. Rüya kommt als CERI-Forschungsteam Mitglied, Mentee und Botschafterin für Kanada zu uns. Sie ist 12 Jahre alt und interessierte sich schon immer für Biologie und Medizin. Rüya ist davon überzeugt, dass die Mitarbeit als Freiwillige bei CERI dazu beitragen wird, das Bewusstsein für und die Krebsprävention zu schärfen und die Menschen über die Krankheit aufzuklären, um Krebs in den frühen Stadien seiner Entwicklung zu erkennen und wirksam zu behandeln.
Wir freuen uns sehr, Rüya in unserem Team zu haben und können es kaum erwarten, ab September ihre Arbeit zu verschiedenen Krebsarten und Krebspräventionsmethoden mit Ihnen zu teilen.